[1]曾穗茹,王蓉梅.孟鲁司特联合布地奈德雾化吸入用于肺炎支原体感染后慢性咳嗽患儿的效果观察[J].医学信息,2018,31(19):137-138,141.[doi:10.3969/j.issn.1006-1959.2018.19.041]
　ZENG Sui-ru,WANG Rong-mei.Efficacy of Montelukast Combined with Budesonide Aerosol Inhalation in Children with Chronic Cough after Mycoplasma Pneumoniae Infection[J].Medical Information,2018,31(19):137-138,141.[doi:10.3969/j.issn.1006-1959.2018.19.041]
点击复制

孟鲁司特联合布地奈德雾化吸入用于肺炎支原体感染后慢性咳嗽患儿的效果观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年19期
页码:
137-138,141
栏目:
药物与临床
出版日期:
2018-10-01

文章信息/Info

Title:
Efficacy of Montelukast Combined with Budesonide Aerosol Inhalation in Children with Chronic Cough after Mycoplasma Pneumoniae Infection
文章编号:
1006-1959（2018）19-0137-03
作者:
曾穗茹; 王蓉梅
乌鲁木齐市第一人民医院呼吸科，新疆 乌鲁木齐 830011
Author(s):
ZENG Sui-ru; WANG Rong-mei
Department of Respiratory,the First People’s Hospital of Urumqi,Urumqi 830011,Xinjiang,China
关键词:
肺炎支原体感染; 慢性咳嗽; 孟鲁司特; 布地奈德; 炎性因子
Keywords:
Mycoplasma pneumoniae infection; Chronic cough; Montelukast; Budesonide; Inflammatory factors
分类号:
R725.6
DOI:
10.3969/j.issn.1006-1959.2018.19.041
文献标志码:
A
摘要:
目的 探讨孟鲁司特联合布地奈德雾化吸入对肺炎支原体感染后慢性咳嗽患儿降钙素原及炎性因子水平的影响。方法选择2016年1月~2018年6月我院收治的肺炎支原体感染后慢性咳嗽患儿106例，按随机数表法分为两组，各53例。对照组给予布地奈德雾化吸入治疗，观察组在此基础上给予孟鲁司特治疗。比较两组治疗后临床疗效、降钙素原水平及炎性因子水平。结果 治疗2个月后，观察组总有效率为94.34%，高于对照组的79.25%，差异有统计学意义（P＜0.05）；治疗2个月后，观察组患儿PCT为（0.45±0.28）μg/L，白介素6（IL-6）为（16.12±5.87） pg/ml，C反应蛋白（CRP）为（7.86±1.59） mg/L。低于对照组（0.68±0.33） μg/L、（29.62±6.05） pg/ml、（12.31±3.25） mg/L，差异有统计学意义（P＜0.05）。结论 孟鲁司特联合布地奈德雾化吸入治疗肺炎支原体感染后慢性咳嗽，可提高临床疗效，降低降钙素原及炎性因子水平。
Abstract:
Objective To investigate the effect of montelukast combined with budesonide aerosol inhalation on the levels of procalcitonin and inflammatory factors in children with chronic cough after mycoplasma pneumoniae infection.Methods 106 children with chronic cough after infection with Mycoplasma pneumoniae from January 2016 to June 2018 were enrolled in our hospital.They were divided into two groups according to the random number table method,53 cases each.The control group was treated with budesonide aerosol inhalation and the observation group with montelukast on this basis.The clinical effect,procalcitonin level and inflammatory factor level were compared between the two groups.Results After 2 months of treatment,the total effective rate of the observation group was 94.34%,which was higher than that of the control group 79.25%,the difference was statistically significant (P<0.05).After 2 months of treatment,the PCT of the observation group was(0.45±0.28) μg/L,interleukin 6(IL-6)was(16.12±5.87) pg/ml,and C-reactive protein (CRP)was(7.86±1.59) mg/L,lower than the control group(0.68±0.33) μg/ L,(29.62 ±6.05) pg/ml,(12.31±3.25) mg/L,the difference was statistically significant(P<0.05). Conclusion Montelukast combined with budesonide aerosol inhalation in the treatment of chronic cough after mycoplasma pneumoniae infection can improve the clinical efficacy and reduce the level of procalcitonin and inflammatory factors.

参考文献/References:

[1]翁泽林,江文文,郑燕霞,等.儿童慢性咳嗽279例常见病因与危险因素分析[J].疑难病杂志,2017,16(2):172-176. [2]王静,丁周志,罗厚江,等.肺炎支原体感染致儿童慢性咳嗽临床分析[J].中华全科医学,2015,13(8):1296-1297,1327. [3]中华医学会儿科学分会呼吸学组慢性咳嗽协作组.中国儿童慢性咳嗽诊断与治疗指南(2013年修订)[J].中华儿科杂志,2014,52(3):184-188. [4]郑桂芬,乔晓红,卢双龙,等.雾化吸入布地奈德治疗儿童肺炎支原体感染后慢性咳嗽的临床疗效[J].中华实用儿科临床杂志,2017,32(22):1705-1708. [5]胡尧.降钙素原在感染性疾病诊断和监测中的应用[J].检验医学,2017,32(3):234-239. [6]黄传君,张永莲,陈方方,等.布地奈德减轻哮喘小鼠气道炎性反应[J].基础医学与临床,2017，37(10):1454-1455. [7]邓俊，杨艳，梁宇佳，等.孟鲁司特对哮喘大鼠气道炎症的调控作用及机制[J].山东医药，2016，56(24):34-36. [8]涂芳芳,曾绮丹,杨芳.孟鲁司特钠联合布地奈德在小儿支原体感染所致慢性咳嗽的临床应用[J].儿科药学杂志,2014,20(6):33-36.

相似文献/References:

[1]杨 桦,杜慧敏.以症状为基础的程序化治疗方案对亚急性、慢性咳嗽的临床有效性研究[J].医学信息,2019,32(08):105.[doi:10.3969/j.issn.1006-1959.2019.08.030]
　YANG Hua,DU Hui-min.Clinical Efficacy of Symptom-based Programmed Treatment for Sub Acute and Chronic Cough[J].Medical Information,2019,32(19):105.[doi:10.3969/j.issn.1006-1959.2019.08.030]
[2]朱晓倩,龚春颖.中医穴位贴敷护理技术在慢性咳嗽中的应用效果[J].医学信息,2021,34(17):190.[doi:10.3969/j.issn.1006-1959.2021.17.053]
　ZHU Xiao-qian,Gong Chun-ying.Application Effect of Traditional Chinese Medicine Acupoint Application Nursing Technique Intervention on Chronic Cough[J].Medical Information,2021,34(19):190.[doi:10.3969/j.issn.1006-1959.2021.17.053]

更新日期/Last Update: 2018-10-29